FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157965205> ?p ?o ?g. }

• W2157965205 endingPage "1232" @default.
• W2157965205 startingPage "1223" @default.
• W2157965205 abstract "Angiotensin converting enzyme inhibitors improve symptoms and prolong life in congestive heart failure, but the dose in the individual patient is uncertain. A randomized, 48-week, double-blind study was performed to investigate the safety and efficacy of 'high' in comparison to continued 'low' angiotensin converting enzyme inhibitor therapy in severe heart failure. Eighty-three patients (56 +/- 1.1 years; 69 men, 14 women) in New York Heart Association functional class III/IV on digoxin, furosemide and 'low' angiotensin converting enzyme inhibitors (captopril < or = 50 mg.day-1 or enalapril < or = 10 mg.day-1) were included. After a > or = 14 day run-in on 10 mg.day-1 enalapril, digitalis and furosemide, right heart catheterization at rest and exercise was performed. All patients presented with atrial pressure > 10 mmHg and/or pulmonary artery pressure > 35 mmHg, and/or cardiac index < 2.5 l.min-1.m-2 at rest. Patients then received enalapril 5 mg twice daily (n = 42), or 20 mg twice daily (n = 41) in random order. Thus, patients randomized to low doses of enalapril actually had no change in therapy from baseline to 48 weeks. Forty-three patients (52%) completed the study, 19 patients on the low dose and 24 patients on the high dose. Both dosages equally influenced survival with 15 (18%) deaths, eight on low dose and seven on high dose. After 48 weeks, functional capacity by New York Heart Association class improved more on the high dose than on the low dose (P = 0.04). In contrast, alterations in invasive haemodynamic variables at rest and exercise as well as maximal exercise capacity were comparable in both groups. Diastolic blood pressure decreased and the change between both groups was statistically significant (P = 0.01). Changes in plasma creatinine levels did not differ between high and low dose treatment and no patients had to be withdrawn because of deterioration in kidney function. With regard to neurohumoral activity, a tendency to a discrepant response to both treatments was observed with a blunted increase in noradrenaline on high versus low enalapril dose. Thus, high-dose enalapril treatment proved superior to low dose as regards symptomatology in severe heart failure after long-term treatment, despite similar effects on haemodynamics and on maximal exercise capacity." @default.
• W2157965205 created "2016-06-24" @default.
• W2157965205 creator A5000240656 @default.
• W2157965205 creator A5000789611 @default.
• W2157965205 creator A5006547876 @default.
• W2157965205 creator A5016223429 @default.
• W2157965205 creator A5017726010 @default.
• W2157965205 creator A5022768129 @default.
• W2157965205 creator A5027029051 @default.
• W2157965205 creator A5035540248 @default.
• W2157965205 creator A5077784612 @default.
• W2157965205 creator A5082697693 @default.
• W2157965205 date "1996-08-02" @default.
• W2157965205 modified "2023-10-11" @default.
• W2157965205 title "Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure" @default.
• W2157965205 cites W1979460197 @default.
• W2157965205 cites W1984193593 @default.
• W2157965205 cites W1993972994 @default.
• W2157965205 cites W1997590659 @default.
• W2157965205 cites W1998245427 @default.
• W2157965205 cites W2006349780 @default.
• W2157965205 cites W2016424925 @default.
• W2157965205 cites W2024584080 @default.
• W2157965205 cites W2051002799 @default.
• W2157965205 cites W2054952495 @default.
• W2157965205 cites W2116291684 @default.
• W2157965205 cites W2135400521 @default.
• W2157965205 cites W2159096663 @default.
• W2157965205 cites W2165404553 @default.
• W2157965205 cites W2585382523 @default.
• W2157965205 cites W2041405033 @default.
• W2157965205 cites W2416572344 @default.
• W2157965205 doi "https://doi.org/10.1093/oxfordjournals.eurheartj.a015040" @default.
• W2157965205 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8869864" @default.
• W2157965205 hasPublicationYear "1996" @default.
• W2157965205 type Work @default.
• W2157965205 sameAs 2157965205 @default.
• W2157965205 citedByCount "60" @default.
• W2157965205 countsByYear W21579652052014 @default.
• W2157965205 countsByYear W21579652052015 @default.
• W2157965205 countsByYear W21579652052017 @default.
• W2157965205 countsByYear W21579652052019 @default.
• W2157965205 countsByYear W21579652052020 @default.
• W2157965205 countsByYear W21579652052022 @default.
• W2157965205 crossrefType "journal-article" @default.
• W2157965205 hasAuthorship W2157965205A5000240656 @default.
• W2157965205 hasAuthorship W2157965205A5000789611 @default.
• W2157965205 hasAuthorship W2157965205A5006547876 @default.
• W2157965205 hasAuthorship W2157965205A5016223429 @default.
• W2157965205 hasAuthorship W2157965205A5017726010 @default.
• W2157965205 hasAuthorship W2157965205A5022768129 @default.
• W2157965205 hasAuthorship W2157965205A5027029051 @default.
• W2157965205 hasAuthorship W2157965205A5035540248 @default.
• W2157965205 hasAuthorship W2157965205A5077784612 @default.
• W2157965205 hasAuthorship W2157965205A5082697693 @default.
• W2157965205 hasBestOaLocation W21579652051 @default.
• W2157965205 hasConcept C126322002 @default.
• W2157965205 hasConcept C164705383 @default.
• W2157965205 hasConcept C178853913 @default.
• W2157965205 hasConcept C27016395 @default.
• W2157965205 hasConcept C2775940317 @default.
• W2157965205 hasConcept C2776445394 @default.
• W2157965205 hasConcept C2777707475 @default.
• W2157965205 hasConcept C2777955127 @default.
• W2157965205 hasConcept C2778198053 @default.
• W2157965205 hasConcept C2779479957 @default.
• W2157965205 hasConcept C2779611605 @default.
• W2157965205 hasConcept C71924100 @default.
• W2157965205 hasConcept C84393581 @default.
• W2157965205 hasConceptScore W2157965205C126322002 @default.
• W2157965205 hasConceptScore W2157965205C164705383 @default.
• W2157965205 hasConceptScore W2157965205C178853913 @default.
• W2157965205 hasConceptScore W2157965205C27016395 @default.
• W2157965205 hasConceptScore W2157965205C2775940317 @default.
• W2157965205 hasConceptScore W2157965205C2776445394 @default.
• W2157965205 hasConceptScore W2157965205C2777707475 @default.
• W2157965205 hasConceptScore W2157965205C2777955127 @default.
• W2157965205 hasConceptScore W2157965205C2778198053 @default.
• W2157965205 hasConceptScore W2157965205C2779479957 @default.
• W2157965205 hasConceptScore W2157965205C2779611605 @default.
• W2157965205 hasConceptScore W2157965205C71924100 @default.
• W2157965205 hasConceptScore W2157965205C84393581 @default.
• W2157965205 hasIssue "8" @default.
• W2157965205 hasLocation W21579652051 @default.
• W2157965205 hasLocation W21579652052 @default.
• W2157965205 hasOpenAccess W2157965205 @default.
• W2157965205 hasPrimaryLocation W21579652051 @default.
• W2157965205 hasRelatedWork W2056493235 @default.
• W2157965205 hasRelatedWork W2079733906 @default.
• W2157965205 hasRelatedWork W2084223257 @default.
• W2157965205 hasRelatedWork W2157965205 @default.
• W2157965205 hasRelatedWork W22745184 @default.
• W2157965205 hasRelatedWork W2413380006 @default.
• W2157965205 hasRelatedWork W2418026461 @default.
• W2157965205 hasRelatedWork W2522552519 @default.
• W2157965205 hasRelatedWork W4251819965 @default.
• W2157965205 hasRelatedWork W2417539937 @default.
• W2157965205 hasVolume "17" @default.

• next